EQUILLIUM, INC. Variable Lease, Cost
EQUILLIUM, INC. (EQ) reported Variable Lease, Cost of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-25
- EQUILLIUM, INC. variable lease, cost for the quarter ending 2025-12-31 was $100.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. variable lease, cost for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. variable lease, cost for the quarter ending 2025-06-30 was $100.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. variable lease, cost for the quarter ending 2025-03-31 was $100.00K, a 0.00% change year-over-year.
- EQUILLIUM, INC. variable lease, cost for fiscal 2025 was $300.00K, a 0.00% change from fiscal 2024.
- EQUILLIUM, INC. variable lease, cost for fiscal 2024 was $300.00K, a 0.00% change from fiscal 2023.
- EQUILLIUM, INC. variable lease, cost for fiscal 2023 was $300.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $200.00K derived: sum of 2 quarters · filed 2026-03-25 | $300.00K derived: sum of 3 quarters · filed 2026-03-25 | $300.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 | $200.00K derived: sum of 2 quarters · filed 2025-11-13 | $200.00K 10-Q · filed 2025-11-13 | $400.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-14 | $100.00K 10-Q · filed 2025-08-14 | $300.00K derived: sum of 3 quarters · filed 2026-03-25 | $400.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-14 | $200.00K derived: sum of 2 quarters · filed 2026-03-25 | $300.00K derived: sum of 3 quarters · filed 2026-03-25 | $400.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $200.00K derived: sum of 2 quarters · filed 2026-03-25 | $300.00K derived: sum of 3 quarters · filed 2026-03-25 | $300.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-13 | $200.00K derived: sum of 2 quarters · filed 2025-11-13 | $200.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-14 | $200.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $300.00K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |